Naoya Horichi

Pharmacokinetics of (glycolato-0,0?)-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin

Yasutsuna Sasaki, Tomohide Tamura, Kenji Eguchi et al. · Cancer Chemotherapy and Pharmacology · 1989 · 97 citations

Medicinal Chemistry, Oncology, -Diammine Platinum +9

Patients Preferences in Chemotherapy for Advanced Non-small-cell Lung Cancer

Takashi Hirose, Naoya Horichi, Tohru Ohmori et al. · Internal Medicine · 2005 · 62 citations · Full text

In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.

Yuichiro Ohe, Kazuhiko Nakagawa, Yasuhiro Fujiwara et al. · PubMed · 1989 · 51 citations

Parental Cell Lines, New Analogues, Medicinal Chemistry +15

Phase II study of irinotecan and carboplatin in patients with the refractory or relapsed small cell lung cancer

Takashi Hirose, Naoya Horichi, Tohru Ohmori et al. · Lung Cancer · 2003 · 43 citations

Medicine, Phase Ii Study, Pathology +5

3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks.

Naoya Horichi, Haïm Tapiero, Yoshikazu Sugimoto et al. · PubMed · 1990 · 36 citations

Bioorganic Chemistry, Chemoprevention Strategy, Cell Death +22